PANTOPAQUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pantopaque, and when can generic versions of Pantopaque launch?
Pantopaque is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in PANTOPAQUE is iophendylate. Additional details are available on the iophendylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PANTOPAQUE?
- What are the global sales for PANTOPAQUE?
- What is Average Wholesale Price for PANTOPAQUE?
Summary for PANTOPAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PANTOPAQUE at DailyMed |
![PANTOPAQUE drug patent expirations Drug patent expirations by year for PANTOPAQUE](/p/graph/s/t/PANTOPAQUE-patent-expirations.png)
US Patents and Regulatory Information for PANTOPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | PANTOPAQUE | iophendylate | INJECTABLE;INJECTION | 005319-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |